Results 251 to 260 of about 35,000 (274)
Some of the next articles are maybe not open access.

[Progress in the diagnosis of carbapenem-resistant Enterobacteriaceae].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology, 2018
Carbapenem-resistant Enterobacteriaceae (CRE) is rising rapidly all over the world, and challenges clinical diagnosis and treatment by various genotypes. This paper summarizes the characteristics and diagnostic methods of CRE. CRE can be divided into three categories and five families with various characteristics and resistant genes.
Fen Qu, Xuan Xu
openaire   +3 more sources

The Emerging Threat From Carbapenem‐Resistant Enterobacteriaceae

Nursing for Women's Health, 2013
The emergence of carbapenem-resistant enterobacteriaceae (CRE) in the United States represents a serious danger to people who are hospitalized and is associated with case mortality rates as high as 50 percent. CRE infections have limited treatment options and the potential to spread widely if prevention and transmission measures are not employed ...
Jessica Landry, Helen Hurst
openaire   +3 more sources

Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections

Expert Review of Anti-infective Therapy, 2019
Introduction: The epidemiology of carbapenem-resistant Enterobacterales (CRE) is increasingly worldwide. Production of carbapenemases is the most common and efficient mechanism of carbapenem resistance, and could theoretically be overcome by optimizing the pharmacokinetic/pharmacodynamic (PK/PD) behavior of meropenem.
Pierluigi Viale   +5 more
openaire   +4 more sources

Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat

Seminars in Diagnostic Pathology, 2019
The first reports of carbapenem resistance in Enterobacteriaceae isolates occurred in the early 1990s. Researchers published the first report of an isolate that produced Klebsiella pneumoniae carbapenemase in 2001. Since that time, carbapenemase-producing Enterobacteriaceae isolates have disseminated globally.
openaire   +3 more sources

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Science, 2017
Mariana X Byndloss; Mariana N Xavier   +2 more
exaly  

Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae

Clinical Microbiology Reviews, 2018
Jesús Rodríguez-Baño   +2 more
exaly  

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

Lancet Infectious Diseases, The, 2008
Kevin B Laupland, Johann D D Pitout
exaly  

Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia

Clinical Microbiology Reviews, 2017
Li Yang Hsu   +2 more
exaly  

The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace

Journal of Infectious Diseases, 2017
Latania K Logan, Robert A Weinstein
exaly  

Home - About - Disclaimer - Privacy